Doug Doerfler

Doug Doerfler

Former President and Chief Executive OfficeratMaxcyte· In proxies 2022–2023

Pay in FY2023+99% from the year before · Maxcyte stock -13.9% the same year

Doug Doerfler was paid $3.1M in FY2023 (Dec), up 99%. Maxcyte stock fell 13.9% that year.

Pay$100 in the stock at the end of FY21 → $46
Pay is from the Summary Compensation Table of each Maxcyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MaxcytePublic company · 4 yr
    • Former President and Chief Executive Officer2022 – Present · 4 yrStock in role -83%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?